What Are First-Generation Antihistamines: Uses & Risks

First-generation antihistamines are the oldest class of allergy drugs, introduced in the 1940s, that block the body’s histamine response but also cross freely into the brain and interfere with several other chemical signaling systems. Common examples include diphenhydramine (Benadryl), chlorpheniramine, hydroxyzine, doxylamine, dimenhydrinate (Dramamine), and cyproheptadine. They remain widely available over the counter despite the fact that major allergy organizations now recommend against routine use, largely because their side-effect profile is far harsher than that of newer alternatives.

How They Work and Why They Make You Drowsy

All antihistamines work by blocking histamine H1 receptors, the docking sites that histamine latches onto when your immune system flags an allergen. When those receptors are blocked in the nose, eyes, and skin, you get relief from sneezing, itching, and hives. The trouble with first-generation drugs is that they do not stop at the body’s periphery. Animal studies using brain-perfusion techniques have shown that first-generation antihistamines penetrate substantially into brain tissue, regardless of the efflux-pump systems that normally keep foreign molecules out.1PubMed Central. Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein Once in the brain, they block histamine receptors that play a role in keeping you awake and alert, which is why drowsiness is the signature side effect.

Brain-imaging studies using PET scans have quantified this difference sharply. A first-generation drug like chlorpheniramine occupies 50% or more of the brain’s H1 receptors at standard doses, while a newer second-generation drug like ebastine occupies roughly 10%.2PubMed Central. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine Similar imaging work found the first-generation drug ketotifen occupied about 72% of brain H1 receptors, compared with about 15% for the second-generation drug olopatadine.3PubMed Central. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen Research on the classification of sedation has established that antihistamines with brain receptor occupancy under about 20% can be considered non-sedating, which is a threshold first-generation drugs routinely blow past.4PubMed Central. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers

Beyond histamine, these drugs also block muscarinic (acetylcholine), alpha-adrenergic, and serotonin receptors. That multi-receptor blockade is responsible for the long list of additional side effects: dry mouth, blurred vision, constipation, urinary difficulty, dizziness from blood-pressure drops, and in some cases appetite stimulation and weight gain.5World Allergy Organization Journal. H1 Antihistamines: Current Status and Future Directions The newer drugs were deliberately designed to stay outside the brain and to avoid these off-target receptor interactions, which is why they cause far fewer problems.

What People Still Use Them For

First-generation antihistamines were originally developed for allergic conditions like hay fever and hives, and they remain effective at relieving those symptoms. However, allergy guidelines now uniformly recommend second-generation drugs as first-line treatment for allergic rhinitis and urticaria, reserving older drugs as a last resort.6PubMed Central. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria The first-generation drugs are no longer recommended for routine allergy management because of their well-documented adverse effects.7Annals of Allergy, Asthma & Immunology. First-Generation Antihistamines: Uses & Risks

So why are they still everywhere? Several reasons. Their sedating and anticholinergic properties have been repurposed for uses that have nothing to do with allergies:

Driving Impairment That Rivals Alcohol

The sedation caused by first-generation antihistamines is not just inconvenient; it can be dangerous. The evidence that these drugs impair driving ability is described as “overwhelming” by a review from the U.S. National Highway Traffic Safety Administration, which documented both objective performance deficits and subjective drowsiness across the experimental literature.12National Highway Traffic Safety Administration. Antihistamines and Driving-Related Behavior: A Review of the Evidence for Impairment

One of the more striking findings comes from a randomized, placebo-controlled driving simulator trial. Participants who took diphenhydramine had worse lane-keeping ability and more frequent center-line crossings than participants who consumed alcohol. In other words, diphenhydramine impaired driving performance more than being legally intoxicated did.13PubMed. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator A second-generation drug tested in the same trial (fexofenadine) caused no significant impairment. Both simulated-driving and real on-road driving studies are used to classify whether a given antihistamine is truly non-sedating, and first-generation drugs consistently fail these tests.14PubMed Central. H1 antihistamines and driving

A common misconception is that tolerance builds quickly, so regular users can drive safely after a few days. While some tolerance to the subjective feeling of drowsiness does develop, objective performance measures often remain impaired even after people report feeling fine. The gap between how drowsy you feel and how impaired you actually are is part of what makes these drugs so risky behind the wheel.

The Dementia Question

One of the more alarming findings in recent years is the possible link between long-term use of anticholinergic drugs, including first-generation antihistamines, and dementia. A large prospective cohort study following older adults for an average of about seven years found that people with the highest cumulative anticholinergic exposure (more than three years’ worth of daily use) had a roughly 54% higher risk of developing dementia compared with nonusers.15PubMed Central. Cumulative Use of Strong Anticholinergic Medications and Incident Dementia The relationship appeared dose-dependent: more exposure tracked with more risk.

A 2024 study focused specifically on first-generation antihistamines in people with allergic rhinitis and found a similar dose-response pattern. Those with the lowest cumulative exposure had a modestly elevated risk, while those at the highest exposure level had about a 51% increased risk of dementia.16PubMed. Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis

The picture is not perfectly clear, though. A large British case-control study found that while certain anticholinergic drug classes (antidepressants, bladder medications, and anti-Parkinson drugs) were associated with increased dementia risk, antihistamines specifically were not, though the number of exposed patients for that subgroup was small.17JAMA Internal Medicine. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study These conflicting results probably reflect differences in how studies measured exposure, which specific drugs were included, and how long people were followed. The weight of the evidence leans toward caution with heavy, prolonged use, particularly in older adults, but there is not yet a scientific consensus that occasional antihistamine use meaningfully raises dementia risk.

Falls and Fractures in Older Adults

For people over 65, the sedation and dizziness caused by first-generation antihistamines translate into a concrete physical danger: falling. A systematic review and meta-analysis found that first-generation antihistamine use roughly doubled the risk of injurious falls or fractures in elderly patients.18PubMed. Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis That finding, combined with the dementia concerns described above, is why geriatric guidelines consistently flag these drugs as potentially inappropriate for older adults. This is not a small issue when you consider how many older people reach for a diphenhydramine-based sleep aid every night.

Risks for Children

In children, first-generation antihistamines can behave unpredictably. The most common adverse effects are the expected ones: sedation, dizziness, and poor coordination. But children are also prone to a paradoxical reaction where the drug produces the opposite of sedation, causing excitation, restlessness, tremors, hallucinations, or even seizures.19Prescriber Update. Sedating Antihistamines and Children This paradoxical stimulation is rare but dramatic enough that parents who give their child a dose of diphenhydramine expecting calm may end up with an agitated, wired child instead. Pediatric guidelines in many countries now advise against using sedating antihistamines in young children for cough and cold symptoms.

Doxylamine in Pregnancy

Pregnancy is one area where a first-generation antihistamine remains a standard-of-care medication. The combination of doxylamine and pyridoxine earned FDA Pregnancy Category A status, meaning well-controlled studies in pregnant women have not shown a risk to the fetus. A re-analysis pooling data from more than 129,000 women in studies involving doxylamine found no increased risk of congenital malformations associated with doxylamine exposure.20PubMed. Re-analysis of safety data supporting doxylamine use for nausea and vomiting of pregnancy In a randomized placebo-controlled trial, the combination reduced nausea and vomiting symptoms more than placebo without important differences in adverse events between groups.21PubMed Central. Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis This remains one of the few genuinely evidence-based uses where a first-generation drug is the preferred choice rather than a fallback.

What Happens in Overdose

Because first-generation antihistamines are inexpensive and sold without a prescription, overdoses are not uncommon, whether accidental or intentional. In large doses, the anticholinergic effects escalate into a recognizable toxicity pattern that emergency physicians learn through a set of clinical mnemonics:

  • Agitation and delirium: CNS muscarinic blockade causes confusion, hallucinations, anxiety, and potentially seizures.
  • Dilated pupils: Blurred vision from pupillary dilation and loss of near-focus accommodation.
  • Dry, flushed skin: Sweat glands stop working, the body overheats, and blood vessels in the skin dilate in a failed attempt to cool down.
  • Urinary retention: The bladder loses muscarinic control.
  • Rapid heart rate: Vagal nerve blockade speeds the heart, and certain drugs like diphenhydramine can also block sodium channels in the heart, causing dangerous rhythm disturbances.22PubMed Central. Anticholinergic Toxicity in the Emergency Department

Treatment in the emergency department starts with stabilizing vital signs and cardiac monitoring. Activated charcoal can sometimes be given even more than an hour after ingestion because these drugs slow gut motility. Benzodiazepines handle agitation and seizures, sodium bicarbonate addresses heart-rhythm problems, and in cases of severe central toxicity, a drug called physostigmine can reverse the anticholinergic effects, though its use requires careful judgment and often toxicology consultation because giving it in the wrong circumstances can cause serious complications.22PubMed Central. Anticholinergic Toxicity in the Emergency Department

Alcohol and First-Generation Antihistamines

Mixing alcohol with any sedating medication is a bad idea, but the interaction with first-generation antihistamines goes beyond simply stacking two sources of drowsiness. Alcohol and histamine share overlapping metabolic pathways in the body, competing for some of the same enzymes. On top of that, alcohol and its breakdown products directly trigger the release of histamine from mast cells while simultaneously inhibiting the enzyme that normally clears histamine from tissues. The result is higher histamine levels in your body at the same time that you have a drug on board trying to block histamine receptors.23Oxford Academic. Alcohol-histamine interactions In practical terms, this means that the combined impairment is unpredictable and potentially severe, affecting everything from reaction time to judgment to coordination.

Heart Rhythm Concerns

Most first-generation antihistamines at recommended doses do not cause clinically significant cardiac problems, but the class is not entirely clean on this front. The broader story of antihistamines and heart safety was shaped by two second-generation drugs, terfenadine and astemizole, which were pulled from the market because they could prolong the heart’s electrical cycle (the QT interval) and trigger a dangerous arrhythmia called torsades de pointes by blocking potassium channels in cardiac tissue.24PubMed Central. Cardiovascular safety of antihistamines That cardiac toxicity is not a universal property of antihistamines as a class, but it prompted closer scrutiny of all members. At overdose levels, as noted above, diphenhydramine and a few other first-generation drugs can cause sodium-channel blockade in the heart, widening the QRS complex on an ECG and potentially leading to dangerous rhythms. This is one reason emergency physicians take large antihistamine overdoses seriously even though many people think of these drugs as harmless.

Why They Remain on Store Shelves

Given the long list of risks, you might wonder why first-generation antihistamines are still sold over the counter with no restrictions in most countries. The Canadian Society of Allergy and Clinical Immunology has called for them to be moved behind the pharmacy counter, arguing that their danger profile warrants at least a conversation with a pharmacist before purchase.6PubMed Central. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria But regulatory change has been slow. These drugs were approved decades before modern safety standards existed, and their widespread use, low cost, and dual marketing as both allergy and sleep medications make them commercially entrenched. Many consumers have no idea that the “PM” in their nighttime cold medicine is just diphenhydramine, or that it carries risks well beyond a good night’s sleep.

The development history matters here. First-generation antihistamines were actually derived from anticholinergic drugs more than 70 years ago, and their non-selective receptor binding was simply the best pharmacology available at the time.25PubMed Central. Pharmacology of antihistamines Second-generation drugs were designed from the ground up to avoid brain penetration and off-target receptor effects. The result is that second- and third-generation antihistamines treat allergies just as effectively for most people without causing drowsiness, driving impairment, dry mouth, or the other problems that come with the older drugs. For straightforward allergy relief, there is rarely a medical reason to choose a first-generation drug anymore. The situations where they still make sense, like pregnancy nausea, motion sickness, or serotonin syndrome, are specific clinical scenarios where their broader receptor activity is actually the point.